MTX, an antifolate chemotherapeutic agent that inhibits DHFR, is widely used in colon cancer treatment.261–265DHFR is able to be amplified in the form of DMs or HSR when cells are treated with MTX. Here, DHFR is linked to colonic neoplasm.